Latest filing published 15 Oct 2026 for Frazier Life Sciences Acquisition Corp. II, €2.7M.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -0.8%Entry US$10.35 · Close 22 Oct 2026 US$10.27
- +45.4%Entry US$15.56 · Close at T+365 US$22.63
- +83.7%Entry US$13.60 · Close at T+365 US$24.98
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Albert Cha: trading record in brief
This profile gathers the share dealings of Albert Cha across 8 companies, led by KalVista Pharmaceuticals, Inc., Sierra Oncology, Inc. and Yarrow Bioscience, Inc. We count 55 filings; the first trade dates from 16 May 2007 and the latest from 15 October 2026.
On the open market, the record shows 23 purchases worth €50.6M and 2 sales worth €1.6M. Taken together, the purchases exceed the sales by €49.0M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant and 2 option exercises. 2026 to date brings 1 purchase and no sales.
In size, the median ticket on the buying side is €490k. Of 15 purchases, 4 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
On 15 October 2026 came the latest disclosure, an open-market purchase for €2.7M in Frazier Life Sciences Acquisition Corp. II. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Albert Cha
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 300,000 shares@ US$10.00100.0% of flowClass A ordinary sharesSEC:0001193125-26-422957:0Canonical exit: 13 Jan 2027 (T+90)
- 12,000 shares@ US$7.880.5% of flowCommon StockSEC:0001209191-23-049268:1
- 18,000 shares@ US$10.500.9% of flowCommon StockSEC:0001209191-23-049268:2
- 6,000 shares@ US$6.71100.0% of flowCommon StockSEC:0001209191-23-049268:0
- 68,255 shares@ US$17.168157.5% of flowCommon StockSEC:0001209191-20-056790:0Canonical exit: 28 Jan 2021 (T+90)
- 47,431 shares@ US$17.335940.4% of flowCommon StockSEC:0001209191-20-056790:1Canonical exit: 28 Jan 2021 (T+90)
- 4,558 shares@ US$16.830.4% of flowCommon StockSEC:0001567619-19-015484:0Canonical exit: 24 Oct 2019 (T+90)
- 21,942 shares@ US$16.831.7% of flowCommon StockSEC:0001567619-19-015484:1Canonical exit: 24 Oct 2019 (T+90)
- 24,730 shares@ US$17.132.0% of flowCommon StockSEC:0001567619-19-015484:2Canonical exit: 27 Oct 2019 (T+90)
- 5,137 shares@ US$17.130.4% of flowCommon StockSEC:0001567619-19-015484:3Canonical exit: 27 Oct 2019 (T+90)
- 1,060 shares@ US$16.970.1% of flowCommon StockSEC:0001567619-19-015022:0Canonical exit: 15 Oct 2019 (T+90)
- 220 shares@ US$16.930.0% of flowCommon StockSEC:0001567619-19-015022:1Canonical exit: 15 Oct 2019 (T+90)
- 10,320 shares@ US$17.680.8% of flowCommon StockSEC:0001567619-19-015022:2Canonical exit: 17 Oct 2019 (T+90)
- 49,680 shares@ US$17.844.1% of flowCommon StockSEC:0001567619-19-015022:3Canonical exit: 17 Oct 2019 (T+90)
- 1,058,824 shares@ US$17.0081.3% of flowCommon StockSEC:0001567619-18-002463:0Canonical exit: 9 Dec 2018 (T+90)
- 72,727 shares@ US$27.5018.0% of flowCommon SharesSEC:0001209191-18-019938:0
- 2,348,550 sharesCommon StockSEC:0001209191-18-005827:2
- 324,306 sharesCommon StockSEC:0001209191-18-005827:3
- 917,559 sharesCommon StockSEC:0001209191-18-005827:4
- 126,703 sharesCommon StockSEC:0001209191-18-005827:5
- 258,432 shares@ US$17.0087.9% of flowCommon StockSEC:0001209191-18-005827:0Canonical exit: 25 Apr 2018 (T+90)
- 35,686 shares@ US$17.0012.1% of flowCommon StockSEC:0001209191-18-005827:1Canonical exit: 25 Apr 2018 (T+90)
- 470,000 shares@ US$17.0082.0% of flowCommon SharesSEC:0001209191-17-030977:1Canonical exit: 7 Aug 2017 (T+90)
- 1,506,818 sharesCommon SharesSEC:0001209191-17-030977:0
- 3,433,646 sharesCommon StockSEC:0001209191-15-075199:0
25 of 47 declarations
